Status:
RECRUITING
Hexadecanal as an Addon to Cognitive Processing Therapy for PTSD
Lead Sponsor:
Tel Aviv University
Collaborating Sponsors:
Weizmann Institute of Science
Conditions:
Post Traumatic Stress Disorder (PTSD)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This RCT investigates whether Cognitive Processing Therapy, a first line treatment for PTSD, can be enhanced by the use of the odor molecule Hexadecenal (HEX). HEX is secreted from body odor and has b...
Detailed Description
In this triple blind (patient, therapist, independent evaluator) RCT, 40 patients with PTSD receiving standard Cognitive Processing Therapy will be randomized in a 1:1 ratio to receive either odorless...
Eligibility Criteria
Inclusion
- Diagnosis of PTSD according to DSM-5
- Age 18 years and over
- Eligible for CPT treatment at the National Center for Traumatic Stress and Resilience
Exclusion
- Bipolar disorder, psychosis, neurological disorders
- Drug Addiction
- Parallel psychotherapy
- Congenital or acquired anosmia.
Key Trial Info
Start Date :
May 5 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06968312
Start Date
May 5 2025
End Date
December 30 2026
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv University
Tel Aviv, Israel, 69978